Follow
Ishwarya Murali
Ishwarya Murali
Postdoctoral fellow, Dana-Farber Cancer Institute
Verified email at dfci.harvard.edu
Title
Cited by
Cited by
Year
Activation of the MAPK pathway mediates resistance to PI3K inhibitors in chronic lymphocytic leukemia
I Murali, S Kasar, A Naeem, S Tyekucheva, JK Khalsa, EM Thrash, ...
Blood, The Journal of the American Society of Hematology 138 (1), 44-56, 2021
402021
Activating MAPK pathway mutations mediate primary resistance to PI3K inhibitors in chronic lymphocytic leukemia (CLL)
I Murali, S Kasar, EM McWilliams, G Itchaki, S Tyekucheva, D Livitz, ...
Blood 132, 587, 2018
192018
pp65 antigenemia and real time polymerase chain reaction (PCR) based-study to determine the prevalence of human cytomegalovirus (HCMV) in kidney donors and recipients with …
HN Madhavan, MY Samson, M Ishwarya, R Vijayakumar, M Jambulingam
Virology Journal 7, 1-7, 2010
152010
The effect of chronic alcohol consumption on mitochondrial calcium handling in hepatocytes
G Wang, E Mémin, I Murali, LD Gaspers
Biochemical Journal 473 (21), 3903-3921, 2016
132016
Functional testing to characterize and stratify PI3K inhibitor responses in chronic lymphocytic leukemia
Y Yin, P Athanasiadis, L Karlsen, A Urban, H Xu, I Murali, SM Fernandes, ...
Clinical Cancer Research 28 (20), 4444-4455, 2022
82022
Genetic events associated with venetoclax resistance in CLL identified by whole-exome sequencing of patient samples
JK Khalsa, J Cha, F Utro, A Naeem, I Murali, Y Kuang, K Vasquez, L Li, ...
Blood 142 (5), 421-433, 2023
72023
Functional testing of PI3K inhibitors stratifies responders to idelalisib and identifies treatment vulnerabilities in idelalisib-refractory/intolerant chronic lymphocytic leukemia
Y Yin, P Athanasiadis, L Karlsen, A Urban, I Murali, SM Fernandes, ...
BioRxiv, 2022.04. 14.488428, 2022
22022
Functional characterization of novel mutations in UL54 of ganciclovir resistant HCMV strain using structural analysis
J Malathi, V Umashankar, R Sathyabaarathi, S Muthukumaran, ...
Bioinformation 5 (9), 390, 2011
22011
Potential Drivers of Acquired Resistance to Idelalisib in CLL Patients
S Yadav, J Khalsa, I Murali, RR Furman, NE Kay, E Braggio, JR Brown
Blood 140 (Supplement 1), 12373-12374, 2022
12022
P626: FUNCTIONAL SCREENING OF PI3K INHIBITORS STRATIFIES RESPONDERS TO IDELALISIB AND INDICATES DRUG CLASS ACTIVITY IN IDELALISIB-REFRACTORY CLL
S Skånland, Y Yanping, P Athanasiadis, L Karlsen, A Urban, I Murali, ...
HemaSphere 6, 525-526, 2022
2022
Mechanisms of primary and acquired resistance to venetoclax in chronic lymphocytic leukemia (CLL)
I Murali, J Cha, I Leshchiner, Y Kuang, K Vasquez, J Khalsa, ...
Cancer Research 81 (13_Supplement), 1097-1097, 2021
2021
ALCOHOL-ASSOCIATED PERTURBATION IN CYTOSOLIC CALCIUM SIGNALING AND MITOCHONDRIAL CALCIUM HANDLING
PJ Bartlett, G Wang, AN Antony, E Memin, I Murali, JB Hoek, LD Gaspers
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH 41, 271A-271A, 2017
2017
Role of Calcium in Nutrient Stimulation of MTORC1
I Murali
Rutgers University, Graduate School of Biomedical Sciences, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–13